Cargando…
Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma
Leveraging the conserved cancer genomes across mammals has the potential to transform driver gene discovery in orphan cancers. Here, we combine cross-species genomics with validation across human–dog–mouse systems to uncover a new bone tumor suppressor gene. Comparative genomics of spontaneous human...
Autores principales: | Shao, Yang W., Wood, Geoffrey A., Lu, Jinchang, Tang, Qing-Lian, Liu, Jonathan, Molyneux, Sam, Chen, Yan, Fang, Hui, Adissu, Hibret, McKee, Trevor, Waterhouse, Paul, Khokha, Rama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756098/ https://www.ncbi.nlm.nih.gov/pubmed/30093633 http://dx.doi.org/10.1038/s41388-018-0444-4 |
Ejemplares similares
-
The MEK2-binding tumor suppressor hDlg is recruited by E-cadherin to the midbody ring
por: Gaudet, Suzanne, et al.
Publicado: (2011) -
The interaction between CASK and the tumour suppressor Dlg1 regulates mitotic spindle orientation in mammalian epithelia
por: Porter, Andrew P., et al.
Publicado: (2019) -
Characterizing the Binding Sites for GK Domain of DLG1 and DLG4 via Molecular Dynamics Simulation
por: Li, Hongwei, et al.
Publicado: (2020) -
DLG5 variants are associated with multiple congenital anomalies including ciliopathy phenotypes
por: Marquez, Jonathan, et al.
Publicado: (2021) -
Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene
por: Barøy, Tale, et al.
Publicado: (2016)